Cazanat Cabozantinib 40mg tablets
Cazanat Cabozantinib 40mg tablets

Cazanat Cabozantinib 40mg tablets

MOQ : 10 Pieces

Cazanat Cabozantinib 40mg tablets Specification

  • Dosage Form
  • Oral solid
  • Pacakaging (Quantity Per Box)
  • 30 Tablets
  • Packaging Type
  • Box
  • Origin of Medicine
  • India
  • Salt Composition
  • Cabozantinib (40 mg)
  • Life Span
  • Refer to expiry date on the packaging
  • Indication
  • Renal cell carcinoma, hepatocellular carcinoma, medullary thyroid cancer
  • Brand Name
  • Cazanat
  • Drug Type
  • Prescription only
  • Ingredients
  • Cabozantinib
  • Physical Form
  • Tablet
  • Function
  • Anticancer / Tyrosine kinase inhibitor
  • Recommended For
  • Adults with certain types of cancer (renal cell carcinoma, hepatocellular carcinoma, and others as prescribed)
  • Dosage
  • As directed by physician, typically 40 mg once daily
  • Dosage Guidelines
  • Swallow whole with water; do not crush or chew; take at the same time each day
  • Suitable For
  • Adults
  • Quantity
  • 30 Tablets per box
  • Storage Instructions
  • Store below 30C, in a dry place, away from light
  • Drug Approval Status
  • Approved in multiple countries for specific indications
  • Prescription/Non-Prescription
  • Prescription
  • Side Effects
  • Diarrhea, fatigue, decreased appetite, nausea, hypertension, hand-foot syndrome (refer package insert for full list)
  • Administration Route
  • Oral
  • Common Brand Names
  • Cabozantinib, Cazanat
  • Contraindications
  • Known hypersensitivity to Cabozantinib or any excipients
  • Country of Export
  • Available internationally, including Canada, UK, USA, Australia, EU
  • Therapeutic Class
  • Oncology / Antineoplastic agents
  • Color
  • Not specified (refer to tablets inside packaging)
 
 

Cazanat Cabozantinib 40mg tablets About



Experience the unparalleled efficacy of Cazanat Cabozantinib 40mg tablets, a top-ranking antineoplastic agent tailored for adults battling renal cell carcinoma, hepatocellular carcinoma, and select cancers. Proudly manufactured in India, this crackerjack oncology brand is renowned for its rare combination of performance and value-a true bargain for patients worldwide. Cazanat is available by prescription and boasts a robust international approval profile, including Canada, the UK, USA, Australia, and the EU. Administered orally, each box contains 30 tablets to empower your treatment journey.

Exclusive Features & Distinct Benefits

Cazanat Cabozantinib 40mg tablets deliver advanced tyrosine kinase inhibition in a reliable oral form. Its primary competitive advantage lies in broad international acceptance and a proven clinical track record. This prescription-only medication stands out with crackerjack efficacy and consistent quality, stored securely below 30C. With a dosage guideline tailored for adults and flexible export supply, Cazanat promises therapeutic precision, backed by rare global approvals and adherence to international safety standards.


International Market Arrival and Certification

As a top-tier therapeutic, Cazanat Cabozantinib 40mg tablets are dispatched globally, reaching clients in Canada, the UK, USA, Australia, and across the EU. We ensure prompt supply and careful dispatching, meeting rigorous international certifications and standards. In the domestic Indian market, Cazanat enjoys widespread clinical trust and consistent demand. Each batch is thoroughly vetted, ensuring that only the best-quality products arrive at their destinations to support vital oncology treatments worldwide.


FAQ's of Cazanat Cabozantinib 40mg tablets:


Q: How should Cazanat Cabozantinib 40mg tablets be taken for best results?

A: Take Cazanat as directed by your physician-typically 40mg once daily. Swallow the tablet whole with water at the same time every day, without crushing or chewing it.

Q: What are the main therapeutic benefits of using Cazanat Cabozantinib 40mg?

A: Cazanat is indicated for the treatment of renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. Its action as a tyrosine kinase inhibitor targets cancer growth effectively in these malignancies.

Q: What side effects should patients be aware of when using Cazanat Cabozantinib?

A: Common side effects include diarrhea, fatigue, decreased appetite, nausea, hypertension, and hand-foot syndrome. Refer to the package insert for a full list and discuss any concerns with your healthcare provider.

Q: Where is Cazanat Cabozantinib 40mg manufactured and available for export?

A: Cazanat is manufactured in India and supplied internationally, including to Canada, the UK, USA, Australia, and the European Union, making it accessible to patients worldwide.

Q: What storage instructions should be followed to maintain Cazanat's potency?

A: Store Cazanat tablets below 30C in a dry place, away from direct light. Always check the expiry date on the packaging before use.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Capsules Category

Weldoxy 100 Doxycycline Capsules

Weldoxy 100 Doxycycline Capsules

Minimum Order Quantity : 100 Boxes

Brand Name : Weldoxy 100

Physical Form : Other, Hard gelatin

Suitable For : Other, Adults and children above 12

Life Span : 24 months

Indication : Respiratory, skin & urinary infections

Primaquine Phosphate Tablets IP

Primaquine Phosphate Tablets IP

Minimum Order Quantity : 10 Pieces

Brand Name : Primaquine Phosphate Tablets IP

Physical Form : Other, Tablet

Suitable For : Other, Adults and children as directed

Life Span : Check expiry on pack

Indication : Radical cure and prevention of relapse in malaria, particularly due to Plasmodium vivax and Plasmodium ovale

Tofacitinib Jaknat Tablet 5mg

Tofacitinib Jaknat Tablet 5mg

Minimum Order Quantity : 10 Pieces

Brand Name : Jaknat

Physical Form : Other, Tablet

Suitable For : Other, Adults (Prescription only)

Life Span : Refer to expiry date on packaging

Indication : Rheumatoid arthritis, Psoriatic arthritis, Ulcerative colitis



Back to top